Philippe DucorPhilippe Ducor

Partner

Associate Professor, University of Geneva School of Law

  • Intellectual Property Law
  • Patents and Technology Transfer
  • Pharmaceutical and Biotechnology Law
  • Medical Malpractice
  • Health Law
  • Commercial Contracts

Email Philippe Ducor

Your email
Your first name and name
Your message
 

 

Education

Admitted to the Bar 1999
University of Geneva: M.D. (Diplôme fédéral de médecin), 1985; Licence en droit, 1991; Doctorat en médecine, 1992
Stanford University, California: J.S.M (Master of the Science of Law), 1994; J.S.D. (Doctorate of the Science of Law), 1996

Career History

Director of the Interdisciplinary Master Program in Life Science Law, University of Geneva, since 2006
Associate Professor of Intellectual Property, Technology Transfer and Biotechnology Law, University of Geneva Law School, since 2004
Lecturer, University of Geneva Law School, 2002-2004
Partner with BMG Avocats, Geneva, since 2002
Lecturer, Master of Business Law program, University of Geneva Law School, since 2000
Lecturer, Post-graduate Program in Intellectual Property NDS-IP, ETH Zurich, since 2000
Associate with BMG Avocats, Geneva, 1999-2002
Patent attorney with Moinas, Savoye & Cronin, Geneva, 1998-1999
Consultant with Fondation BioStart, SDES (Société pour le Développement de l'Economie Suisse), various academic partners, 1996-1998
Consultant with Interwerst Partners (venture capital firm), Menlo Park, California, 1996-1997
Medical Practitioner in emergency medicine, Geneva, 1997-1999
Research Fellow in Biotechnology Law, Prof. John Barton, Stanford Law School, 1995-1996
Advanced researcher grant from the Swiss National Science Foundation, 1993-1996
Resident in forensic medicine, University of Geneva, 1992-1993
Clinic Chief in internal medicine, Hôpital de la Tour, Meyrin, Geneva, 1991-1992
Resident in internal medicine and legal medicine, Geneva University Hospital and Hôpital de la Tour, Meyrin, Geneva, 1985-1991

Memberships

Geneva Bar Association
Swiss Bar Association
University of Geneva Professors Association
Swiss Lawpractitionners Society
International Association for the Protection of Intellectual Property (AIPPI)
Licensing Executives Society (LES)
Geneva Association of Business Lawyers (AGDA)
Swiss Arbitration Association (ASA)
Swiss Medical Association (FMH)
Geneva Medical Association (AMG)

Languages

French and English

Publications

"Commentaire Romand de la LDIP et de la Convention de Lugano", Chapters relating to Intellectual Property, Andreas Bucher editor [en preparation]

"L’expert médical et la causalité", article to be published in the minutes of the Journée de la Responsabilité Civile 2006, Christine Chappuis et Benedict Winiger editors

"Fautes médicales: trousse d’urgence pour le praticien", Revue Médicale Suisse, Vol. 3, 2007, p. 36.

"Protection des bases de données et Loi contre la Concurrence Déloyale", in Internet 2003, CEDIDAC 2004, Lausanne, p. 153-184

"Genetic Tests, Benefit-Sharing and Patents: Conflict?" Presented at the conference "Ethics and Intellectual Property: Toward an Understanding of Benefit Sharing", Center for Bioethics, University of Pennsylvania, March 3, 2003 [Collective publication will follow]

"Accès aux Ressources Génétiques en Suisse", Cahiers de l’Environnement No. 359, 2003

"Aspects Juridiques des Ecrits Médicaux", Médecine et Hygiène, 2003, p. 30-31

"Biological Material Transfer Agreements", Revue Suisse de Droit des Affaires, 6/2002, p. 317-330

"Coauthorship and Coinventorship", Science Vol. 289, 873-875 (2000)

"Research Tools Patents and Experimental Use Exemption: A No-Win?", Nature Biotechnology, Vol. 17, 18 (1999)

"Ein Zentrum für Technologietransfer. Von "publish or perish" zu "patent or perish", Neue Zürcher Zeitung, 10 March 1998, p.18

"Are Patents and Research Compatible?", Nature Vol. 387, 13-14 (1997)

"Recombinant Inventions and Non Obviousness: A Typology." 13 Santa Clara Computer and High Technology Law Journal 1-69 (1997)

"Patenting the Recombinant Products of Biotechnology and Other Molecules", Kluwer Law International, London, The Hague, Boston 1998 (179p)

"The Federal Circuit and In re Deuel: Does §103 Apply to Naturally Occurring DNA?" 77 Journal of the Patent & Trademark Office Society 871-898 (1995)

"The Legal Status of Human Materials." 44 Drake Law Review 195-259 (1996)

"In re Deuel: Biotechnology Industry v. Patent Law?" 18 European Intellectual Property Review 35-46 (1996)

"New Drug Discovery Technologies and Patents." 22 Rutgers Computers & Technology Law Journal, 369-377 (1996)

 

©2010. Copyright BMG Avocats. All rights reserved.

Legal disclaimer.